Effect of oral voriconazole on fungal keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II) a randomized clinical trial

JAMA Ophthalmology

Volumn 134, Issue 12, 2016, Pages 1365-1372

  Prajna, N Venkatesh ^a   Krishnan, Tiruvengada ^a   Rajaraman, Revathi ^a   Patel, Sushila ^b   Srinivasan, Muthiah ^a   Das, Manoranjan ^a   Ray, Kathryn J ^c   O'Brien, Kieran S ^c   Oldenburg, Catherine E ^c   McLeod, Stephen D ^c,d   Zegans, Michael E ^e   Porco, Travis C ^c,d   Acharya, Nisha R ^c,d   Lietman, Thomas M ^c,d   Rose Nussbaumer, Jennifer ^a,c,d  

^a ARAVIND EYE CARE SYSTEM   (India)

^b Lumbini Eye Hospital   (Nepal)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; NATAMYCIN; PLACEBO; VORICONAZOLE; ANTIFUNGAL AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLERGIC REACTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEST CORRECTED VISUAL ACUITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORNEA PERFORATION; CORNEA ULCER; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOPHTHALMITIS; EPITHELIZATION; EYE DISEASE; EYE EVISCERATION; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEART INFARCTION; HUMAN; HYPOPYON; INDIA; KERATOMYCOSIS; LETHARGY; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NAUSEA; NEPAL; OUTCOME ASSESSMENT; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMEAR; STOMACH PAIN; VISUAL DISORDER; VOMITING; AGED; CLINICAL TRIAL; CORNEA; CORNEAL ULCER; DOSE RESPONSE; EYE INFECTIONS, FUNGAL; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIFUNGAL AGENTS; CORNEA; CORNEAL ULCER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EYE INFECTIONS, FUNGAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VORICONAZOLE;

EID: 85011422424     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2016.4096     Document Type: Article

References (33)

1. Gopinathan U, Garg P, FernandesM, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea. 2002;21(6):555-559.
2. FlorCruz NV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database Syst Rev. 2015; (4):CD004241.
3. Feilmeier MR, Sivaraman KR, OlivaM, Tabin GC, Gurung R. Etiologic diagnosis of corneal ulceration at a tertiary eye center in Kathmandu, Nepal. Cornea. 2010;29(12):1380-1385.
4. Dunlop AA,Wright ED, Howlader SA, et al. Suppurative corneal ulceration in Bangladesh: a study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis.Aust N Z J Ophthalmol. 1994;22(2):105-110.
5. Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J. 1997;23(4): 275-281.
6. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol. 1997;81(11):965-971.
7. Whitcher JP, Srinivasan M. Corneal ulceration in the developing world-A silent epidemic. Br J Ophthalmol. 1997;81(8):622-623.
8. Verma S, Tuft SJ. Fusarium solani keratitis following LASIK formyopia. Br J Ophthalmol. 2002; 86(10):1190-1191.
9. Bernal MD, Acharya NR, Lietman TM, Strauss EC, McLeod SD, Hwang DG. Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco. Arch Ophthalmol. 2006;124(7):1051-1053.
10. Yildiz EH, Abdalla YF, Elsahn AF, et al. Update on fungal keratitis from 1999 to 2008. Cornea. 2010;29(12):1406-1411.
11. Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92(7):871-878.
12. Loh AR, Hong K, Lee S, Mannis M, Acharya NR. Practice patterns in the management of fungal corneal ulcers. Cornea. 2009;28(8):856-859.
13. Walsh TJ, Pappas P, Winston DJ, et al; National Institute of Allergy and Infectious DiseasesMycoses Study Group. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002;346(4):225-234.
14. Prajna NV, Krishnan T, Mascarenhas J, et al; Mycotic Ulcer Treatment Trial Group. The Mycotic Ulcer Treatment Trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131(4):422-429.
15. Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother. 2007;51(1):239-244.
16. O'Day DM, HeadWS, Robinson RD, Clanton JA. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res. 1986;5(11):877-882.
17. World Medical Association.World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194.
18. Denning DW, Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis. 2002;34(5): 563-571.
19. Purkins L,Wood N, Ghahramani P, Greenhalgh K, Allen MJ, Kleinermans D. Pharmacokinetics and safety of voriconazole following intravenous-to oral-dose escalation regimens. Antimicrob Agents Chemother. 2002;46(8):2546-2553.
20. Wilhelmus KR, Gee L, HauckWW, et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1883-1895.
21. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no.1. Control Clin Trials. 1999;20(6):573-600.
22. Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130(2):143-150.
23. Lalitha P, Prajna NV, Oldenburg CE, et al. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea. 2012;31(6):662-667.
24. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65-70.
25. Zrenner E, Tomaszewski K, Hamlin J, Layton G, Wood N. Effects of multiple doses of voriconazole on the vision of healthy volunteers: a double-blind, placebo-controlled study. Ophthalmic Res. 2014; 52(1):43-52.
26. Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/pharmacodynamic profile of voriconazole. Clin Pharmacokinet. 2006;45(7): 649-663.
27. Lalitha P, Sun CQ, Prajna NV, et al; Mycotic Ulcer Treatment Trial Group. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial. Am J Ophthalmol. 2014;157(2): 318-326.
28. Sharma S, Das S, Virdi A, et al. Re-appraisal of topical 1% voriconazole and 5%natamycin in the treatment of fungal keratitis in a randomised trial. Br J Ophthalmol. 2015;99(9):1190-1195.
29. Hernández Prats C, Llinares Tello F, Burgos San José A, Selva Otaolaurruchi J, Ordovás Baines JP. Voriconazole in fungal keratitis caused by Scedosporium apiospermum. Ann Pharmacother. 2004;38(3):414-417.
30. Jones A, Muhtaseb M. Use of voriconazole in fungal keratitis. J Cataract Refract Surg. 2008;34 (2):183-184.
31. Parchand S, Gupta A, RamJ, Gupta N, Chakrabarty A. Voriconazole for fungal corneal ulcers. Ophthalmology. 2012;119(5):1083.
32. Rajaraman R, Bhat P, Vaidee V, et al. Topical 5% natamycin with oral ketoconazole in filamentous fungal keratitis: a randomized controlled trial. Asia Pac J Ophthalmol (Phila). 2015;4(3):146-150.
33. Sun CQ, Prajna NV, Krishnan T; Mycotic Ulcer Treatment Trial Group. Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis [published online June 21, 2016]. Clin Exp Ophthalmol. doi:10.1111/ceo.12794